SHPH - Dinamika pendapatan YoY sajrone rolas wulan kepungkur shuttlepharma.com

Logo perusahaan publik Shuttle Pharmaceuticals (SHPH)

Shuttle Pharmaceuticals (SHPH) total dependence on third-party laboratories and contractors contrasts with the development of breakthrough methods for enhancing radiation impact on brain tumors. This trailing twelve-month revenue chart helps correlate these factors, where 0.00 represents the current metric level. Currently, the business relies on the gradual depletion of existing cash reserves to fund critical scientific research.

SHPH shuttlepharma.com: Wutah pendapatan YoY sajrone 12 wulan kepungkur ing interval 11.02.2024 - 16.11.2026

Ringkesan rincian data analitis Shuttle Pharmaceuticals Holdings (SHPH)

- nilai saham lan prakiraan konsensus rega:
Ringkesan analitik perusahaan:Shuttle Pharmaceuticals
Sampel barang shuttlepharma.com

This indicator measures revenue dynamics over a rolling twelve-month period, allowing for an assessment of the actual business scaling speed and the risk of capital stagnation. By analyzing the Last Twelve Months (LTM) change in trading revenue, an investor can compare the sales growth rates of Shuttle Pharmaceuticals (SHPH) radiosensitizers with the expansion of oncology centers to determine the market potential of brain cancer therapy drugs.

Analisis pesaing Shuttle Pharmaceuticals